1. Antidepressant versus placebo: self‐injurious behaviour results that could not be used in meta‐analyses.
Study name | Short‐/ medium‐/ long‐term outcomes | Group 1 | Group 2 | Group 1 sample size | Group 2 sample size | Group 1 results | Group 2 results | Other data | Notes |
Carminati 2016 | Short‐term self‐injurious behaviour | Venlafaxine 18.75 mg/day | Placebo | 6 | 7 | Median 1 (range 0‐13) | Median 3 (range 0‐8) | ‐ | ‐ |
King 2001 | Short‐term self‐injurious behaviour | Citalopram (max 20 mg/day) | Placebo | 73 | 76 | 2.4 (2.7) | 2.0 (2.6) | ‐ | Skewed |
Mouti 2014 | Short‐term self‐injurious behaviour | Fluoxetine (max 20‐30 mg) | Placebo | 53 | 53 | 2.09 (3.01) | 3.55 (4.59) | ‐ | Skewed |